Devanjan Sikder Selected Research

Immunotherapy

11/2021

A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti-PD-1 Agent Pembrolizumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Devanjan Sikder Research Topics

Disease

3	Neoplasms (Cancer) 11/2021 - 11/2007
3	Obesity 11/2013 - 10/2011
2	Multiple Myeloma 01/2022 - 09/2021
2	Narcolepsy 10/2011 - 11/2007
2	Hypoxia (Hypoxemia) 04/2009 - 11/2007
1	Pleural Diseases 11/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2021
1	Weight Gain 10/2013
1	Body Weight (Weight, Body) 10/2011
1	Heart Failure 02/2011
1	Cardiomegaly (Heart Hypertrophy) 04/2009
1	Multiple Sclerosis 11/2004
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2004

Drug/Important Bio-Agent (IBA)

4	OrexinsIBA 11/2013 - 11/2007
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2022 - 09/2021
2	Proteins (Proteins, Gene)FDA Link 02/2011 - 04/2009
2	CalcineurinIBA 02/2011 - 04/2009
2	Transcription Factors (Transcription Factor)IBA 04/2009 - 11/2007
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022
1	pembrolizumabIBA 11/2021
1	MesothelinIBA 11/2021
1	Chimeric Antigen ReceptorsIBA 09/2021
1	NeuropeptidesIBA 10/2013
1	CytoglobinIBA 04/2009
1	Hypoxia-Inducible Factor 1IBA 11/2007
1	Neurotransmitter Agents (Neurotransmitter)IBA 11/2007
1	Antisense OligonucleotidesIBA 11/2004
1	AntigensIBA 11/2004
1	Small Interfering RNA (siRNA)IBA 11/2004
1	OligonucleotidesIBA 11/2004

Therapy/Procedure

2	Therapeutics 09/2021 - 11/2004
1	Immunotherapy 11/2021
1	Blood Component Removal (Apheresis) 09/2021